Header Logo

Connection

STEPHEN YENZEN LAI to Male

Back to Details
This is a "connection" page, showing publications STEPHEN YENZEN LAI has written about Male.
STEPHEN YENZEN LAI
Connection Strength
0.704
Male
  1. First-in-Human Hyperpolarized MRI for Tumor Metabolism in HNSCC. JAMA Otolaryngol Head Neck Surg. 2024 Jul 01; 150(7):628-630.
    View in: PubMed
    Score: 0.029
  2. Analysis of Dispensing and Utilization Patterns of Medical Cannabis Products in State Licensed Cannabis Dispensaries. J Palliat Med. 2023 11; 26(11):1482-1487.
    View in: PubMed
    Score: 0.027
  3. Novel Anaplastic Thyroid Cancer PDXs and Cell Lines: Expanding Preclinical Models of Genetic Diversity. J Clin Endocrinol Metab. 2021 10 21; 106(11):e4652-e4665.
    View in: PubMed
    Score: 0.024
  4. Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study. Int J Radiat Oncol Biol Phys. 2020 12 01; 108(5):1319-1328.
    View in: PubMed
    Score: 0.022
  5. Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic. Head Neck. 2020 06; 42(6):1194-1201.
    View in: PubMed
    Score: 0.022
  6. Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era. Head Neck. 2020 06; 42(6):1179-1186.
    View in: PubMed
    Score: 0.022
  7. Incompletely treated malignancies of the major salivary gland: Toward evidence-based care. Head Neck. 2018 08; 40(8):1630-1638.
    View in: PubMed
    Score: 0.019
  8. Facilitating anaplastic thyroid cancer specialized treatment: A model for improving access to multidisciplinary care for patients with anaplastic thyroid cancer. Head Neck. 2017 07; 39(7):1291-1295.
    View in: PubMed
    Score: 0.017
  9. Treatment and survival of patients with insular thyroid carcinoma: 508 cases from the National Cancer Data Base. Head Neck. 2016 06; 38(6):906-12.
    View in: PubMed
    Score: 0.016
  10. Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia. Thyroid. 2015 Jul; 25(7):834-8.
    View in: PubMed
    Score: 0.015
  11. In reply. Oncologist. 2014 Aug; 19(8):e4.
    View in: PubMed
    Score: 0.014
  12. Gastrostomy tube placement in patients with hypopharyngeal cancer treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck. 2013 Nov; 35(11):1641-6.
    View in: PubMed
    Score: 0.013
  13. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther. 2012 Jun; 11(6):1373-80.
    View in: PubMed
    Score: 0.012
  14. Targeted therapy of VEGFR2 and EGFR significantly inhibits growth of anaplastic thyroid cancer in an orthotopic murine model. Clin Cancer Res. 2011 Apr 15; 17(8):2281-91.
    View in: PubMed
    Score: 0.011
  15. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys. 2009 Dec 01; 75(5):1493-500.
    View in: PubMed
    Score: 0.010
  16. Intratumoral epidermal growth factor receptor antisense DNA therapy in head and neck cancer: first human application and potential antitumor mechanisms. J Clin Oncol. 2009 Mar 10; 27(8):1235-42.
    View in: PubMed
    Score: 0.010
  17. Minimally invasive video-assisted thyroidectomy: expanded indications and oncologic completeness. Head Neck. 2008 Nov; 30(11):1403-7.
    View in: PubMed
    Score: 0.010
  18. Treatment and survival outcomes based on histologic grading in patients with head and neck mucoepidermoid carcinoma. Cancer. 2008 Oct 15; 113(8):2082-9.
    View in: PubMed
    Score: 0.010
  19. Activated Vav2 modulates cellular invasion through Rac1 and Cdc42 in oral squamous cell carcinoma. Oral Oncol. 2008 Jul; 44(7):683-8.
    View in: PubMed
    Score: 0.009
  20. Erythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinoma. Oncogene. 2005 Jun 23; 24(27):4442-9.
    View in: PubMed
    Score: 0.008
  21. Cluster-Based Toxicity Estimation of Osteoradionecrosis Via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification. Int J Radiat Oncol Biol Phys. 2024 Aug 01; 119(5):1569-1578.
    View in: PubMed
    Score: 0.007
  22. Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis. Otolaryngol Head Neck Surg. 2024 May; 170(5):1319-1330.
    View in: PubMed
    Score: 0.007
  23. Canadian French Translation and Validation of the Neck Dissection Impairment Index: A Quality of Life Measure for the Surgical Oncology Population. J Otolaryngol Head Neck Surg. 2024 Jan-Dec; 53:19160216241263852.
    View in: PubMed
    Score: 0.007
  24. Resistance to Human Immunodeficiency Virus 1 Infection Conferred by a Compound CCR5?32 and CCR5 C20S Heterozygote. J Infect Dis. 2023 07 14; 228(2):116-121.
    View in: PubMed
    Score: 0.007
  25. Prior Thyroid and Nonthyroid Cancer History Do Not Significantly Alter Overall Survival in Patients Diagnosed with Anaplastic Thyroid Cancer. Thyroid. 2023 03; 33(3):321-329.
    View in: PubMed
    Score: 0.007
  26. The combined profunda artery perforator-gracilis flap for immediate facial reanimation and resurfacing of the radical parotidectomy defect. Microsurgery. 2023 May; 43(4):309-315.
    View in: PubMed
    Score: 0.006
  27. Sphenoid encephaloceles: disease management and identification of lesions within the lateral recess of the sphenoid sinus. Laryngoscope. 2002 Oct; 112(10):1800-5.
    View in: PubMed
    Score: 0.006
  28. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia. JAMA Otolaryngol Head Neck Surg. 2022 10 01; 148(10):956-964.
    View in: PubMed
    Score: 0.006
  29. Parotidectomy in the treatment of aggressive cutaneous malignancies. Arch Otolaryngol Head Neck Surg. 2002 May; 128(5):521-6.
    View in: PubMed
    Score: 0.006
  30. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. 2021 07 01; 147(7):615-623.
    View in: PubMed
    Score: 0.006
  31. Normal Tissue Complication Probability (NTCP) Prediction Model for Osteoradionecrosis of the Mandible in Patients With Head and Neck Cancer After Radiation Therapy: Large-Scale Observational Cohort. Int J Radiat Oncol Biol Phys. 2021 10 01; 111(2):549-558.
    View in: PubMed
    Score: 0.006
  32. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. JAMA Otolaryngol Head Neck Surg. 2021 05 01; 147(5):469-478.
    View in: PubMed
    Score: 0.006
  33. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer. 2020 Sep 23; 20(1):912.
    View in: PubMed
    Score: 0.006
  34. Evaluation of Overall Survival in Patients With Anaplastic Thyroid Carcinoma, 2000-2019. JAMA Oncol. 2020 09 01; 6(9):1397-1404.
    View in: PubMed
    Score: 0.005
  35. Biomechanical modeling of radiation dose-induced volumetric changes of the parotid glands for deformable image registration. Phys Med Biol. 2020 08 31; 65(16):165017.
    View in: PubMed
    Score: 0.005
  36. Self-Reported Trismus: prevalence, severity and impact on quality of life in oropharyngeal cancer survivorship: a cross-sectional survey report from a comprehensive cancer center. Support Care Cancer. 2021 Apr; 29(4):1825-1835.
    View in: PubMed
    Score: 0.005
  37. Swallowing-related outcomes associated with late lower cranial neuropathy in long-term oropharyngeal cancer survivors: cross-sectional survey analysis. Head Neck. 2019 11; 41(11):3880-3894.
    View in: PubMed
    Score: 0.005
  38. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in BRAFV600E-Mutated Anaplastic Thyroid Carcinoma. Thyroid. 2019 08; 29(8):1036-1043.
    View in: PubMed
    Score: 0.005
  39. Incidental detection of oropharyngeal cancer with fluciclovine PET. Head Neck. 2019 08; 41(8):E141-E145.
    View in: PubMed
    Score: 0.005
  40. Development and Characterization of a Rabbit Model of Compromised Maxillofacial Wound Healing. Tissue Eng Part C Methods. 2019 03; 25(3):160-167.
    View in: PubMed
    Score: 0.005
  41. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer. 2019 06 01; 125(11):1823-1829.
    View in: PubMed
    Score: 0.005
  42. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Laryngoscope. 2020 01; 130(1):146-153.
    View in: PubMed
    Score: 0.005
  43. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive. JCO Clin Cancer Inform. 2019 02; 3:1-9.
    View in: PubMed
    Score: 0.005
  44. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer. 2019 05 15; 125(10):1654-1664.
    View in: PubMed
    Score: 0.005
  45. Symptom Burden Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Cancer Survivors. JAMA Otolaryngol Head Neck Surg. 2018 11 01; 144(11):1066-1076.
    View in: PubMed
    Score: 0.005
  46. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654.
    View in: PubMed
    Score: 0.005
  47. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling. BMC Cancer. 2018 Sep 19; 18(1):903.
    View in: PubMed
    Score: 0.005
  48. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer. Thyroid. 2018 08; 28(8):982-990.
    View in: PubMed
    Score: 0.005
  49. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry. Radiother Oncol. 2018 09; 128(3):442-451.
    View in: PubMed
    Score: 0.005
  50. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck. 2018 09; 40(9):2060-2069.
    View in: PubMed
    Score: 0.005
  51. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol. 2018 04; 28(2):108-113.
    View in: PubMed
    Score: 0.005
  52. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol. 2018 04; 79:1-8.
    View in: PubMed
    Score: 0.005
  53. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2018 02 01; 144(2):108-114.
    View in: PubMed
    Score: 0.005
  54. Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer. JAMA Otolaryngol Head Neck Surg. 2017 12 01; 143(12):1244-1251.
    View in: PubMed
    Score: 0.005
  55. Cough strength and expiratory force in aspirating and nonaspirating postradiation head and neck cancer survivors. Laryngoscope. 2018 07; 128(7):1615-1621.
    View in: PubMed
    Score: 0.005
  56. Management of the lateral neck compartment in patients with sporadic medullary thyroid cancer. Head Neck. 2018 Jan; 40(1):79-85.
    View in: PubMed
    Score: 0.005
  57. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65?years old. Radiat Oncol. 2017 Sep 09; 12(1):150.
    View in: PubMed
    Score: 0.004
  58. Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades. Dysphagia. 2018 04; 33(2):185-191.
    View in: PubMed
    Score: 0.004
  59. Expiratory muscle strength training for radiation-associated aspiration after head and neck cancer: A case series. Laryngoscope. 2018 05; 128(5):1044-1051.
    View in: PubMed
    Score: 0.004
  60. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow. Radiat Oncol. 2017 Aug 15; 12(1):129.
    View in: PubMed
    Score: 0.004
  61. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck. 2017 10; 39(10):2048-2056.
    View in: PubMed
    Score: 0.004
  62. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions. Radiother Oncol. 2017 08; 124(2):248-255.
    View in: PubMed
    Score: 0.004
  63. Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy. Oral Oncol. 2017 09; 72:90-97.
    View in: PubMed
    Score: 0.004
  64. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol. 2017 06; 123(3):401-405.
    View in: PubMed
    Score: 0.004
  65. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck. 2017 08; 39(8):1609-1620.
    View in: PubMed
    Score: 0.004
  66. Patterns of Treatment Failure in Anaplastic Thyroid Carcinoma. Thyroid. 2017 05; 27(5):672-681.
    View in: PubMed
    Score: 0.004
  67. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis. Oral Oncol. 2017 03; 66:75-80.
    View in: PubMed
    Score: 0.004
  68. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. Cancer. 2017 05 01; 123(9):1653-1661.
    View in: PubMed
    Score: 0.004
  69. Real-Time Genomic Characterization Utilizing Circulating Cell-Free DNA in Patients with Anaplastic Thyroid Carcinoma. Thyroid. 2017 01; 27(1):81-87.
    View in: PubMed
    Score: 0.004
  70. Feeding Tube Utilization in Patients with Salivary Gland Malignancies. Otolaryngol Head Neck Surg. 2017 01; 156(1):109-117.
    View in: PubMed
    Score: 0.004
  71. Reduced feeding tube duration with intensity-modulated radiation therapy for head and neck cancer: A Surveillance, Epidemiology, and End Results-Medicare Analysis. Cancer. 2017 01 01; 123(2):283-293.
    View in: PubMed
    Score: 0.004
  72. Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation. Cancer. 2017 Jan 01; 123(1):62-70.
    View in: PubMed
    Score: 0.004
  73. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck. 2016 12; 38(12):1739-1751.
    View in: PubMed
    Score: 0.004
  74. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope. 2017 04; 127(4):842-848.
    View in: PubMed
    Score: 0.004
  75. Long-Term, Prospective Performance of the MD?Anderson Dysphagia Inventory in "Low-Intermediate Risk" Oropharyngeal Carcinoma After Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2017 03 15; 97(4):700-708.
    View in: PubMed
    Score: 0.004
  76. Development and Feasibility of a Specialty-Specific National Surgical Quality Improvement Program (NSQIP): The Head and Neck-Reconstructive Surgery NSQIP. JAMA Otolaryngol Head Neck Surg. 2016 Apr; 142(4):321-7.
    View in: PubMed
    Score: 0.004
  77. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol. 2016 06; 57:1-5.
    View in: PubMed
    Score: 0.004
  78. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck. 2016 04; 38 Suppl 1:E1962-8.
    View in: PubMed
    Score: 0.004
  79. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol. 2016 Feb; 118(2):315-22.
    View in: PubMed
    Score: 0.004
  80. Improving patient outcomes through multidisciplinary treatment planning conference. Head Neck. 2016 04; 38 Suppl 1:E1820-5.
    View in: PubMed
    Score: 0.004
  81. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol. 2016 Jul-Aug; 6(4):241-247.
    View in: PubMed
    Score: 0.004
  82. Association of TERT Promoter Mutation, But Not BRAF Mutation, With Increased Mortality in PTC. J Clin Endocrinol Metab. 2015 Dec; 100(12):E1550-9.
    View in: PubMed
    Score: 0.004
  83. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer. 2016 Mar 01; 138(5):1290-7.
    View in: PubMed
    Score: 0.004
  84. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res. 2015 Nov 15; 75(22):4708-17.
    View in: PubMed
    Score: 0.004
  85. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. Semin Oncol. 2015 Dec; 42(6):915-22.
    View in: PubMed
    Score: 0.004
  86. Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer. Biomaterials. 2015 Jul; 57:41-9.
    View in: PubMed
    Score: 0.004
  87. An audit and feedback system for effective quality improvement in head and neck surgery: Can we become better surgeons? Cancer. 2015 May 15; 121(10):1581-7.
    View in: PubMed
    Score: 0.004
  88. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications? Pract Radiat Oncol. 2015 Jul-Aug; 5(4):e299-308.
    View in: PubMed
    Score: 0.004
  89. Lymphedema outcomes in patients with head and neck cancer. Otolaryngol Head Neck Surg. 2015 Feb; 152(2):284-291.
    View in: PubMed
    Score: 0.004
  90. Sorafenib in metastatic thyroid cancer: a systematic review. Oncologist. 2014 Mar; 19(3):251-8.
    View in: PubMed
    Score: 0.003
  91. Eat and exercise during radiotherapy or chemoradiotherapy for pharyngeal cancers: use it or lose it. JAMA Otolaryngol Head Neck Surg. 2013 Nov; 139(11):1127-34.
    View in: PubMed
    Score: 0.003
  92. Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas. Ophthalmic Plast Reconstr Surg. 2013 Nov-Dec; 29(6):454-7.
    View in: PubMed
    Score: 0.003
  93. Gastrostomy tube placement in patients with oropharyngeal carcinoma treated with radiotherapy or chemoradiotherapy: factors affecting placement and dependence. Head Neck. 2013 Nov; 35(11):1634-40.
    View in: PubMed
    Score: 0.003
  94. Superimposed infection in mandibular osteoradionecrosis: diagnosis and outcomes. J Comput Assist Tomogr. 2012 Nov-Dec; 36(6):725-31.
    View in: PubMed
    Score: 0.003
  95. Phosphaturic mesenchymal tumor: a report of 6 patients treated at a single institution and comparison with reported series. Ann Diagn Pathol. 2013 Aug; 17(4):319-21.
    View in: PubMed
    Score: 0.003
  96. A throughput-optimized array system for multiple-mouse MRI. NMR Biomed. 2013 Mar; 26(3):237-47.
    View in: PubMed
    Score: 0.003
  97. Chemoradiotherapy for maxillary sinus adenoid cystic carcinoma using superselective intra-arterial infusion via a superficial temporal artery. Head Neck. 2013 Mar; 35(3):E89-93.
    View in: PubMed
    Score: 0.003
  98. Phase I trial of pemetrexed in combination with cetuximab and concurrent radiotherapy in patients with head and neck cancer. Ann Oncol. 2011 Nov; 22(11):2482-2488.
    View in: PubMed
    Score: 0.003
  99. Prognostic factors in patients with high-risk locally advanced salivary gland cancers treated with surgery and postoperative radiotherapy. Head Neck. 2011 Mar; 33(3):318-23.
    View in: PubMed
    Score: 0.003
  100. Induction docetaxel, cisplatin, and cetuximab followed by concurrent radiotherapy, cisplatin, and cetuximab and maintenance cetuximab in patients with locally advanced head and neck cancer. J Clin Oncol. 2010 Dec 20; 28(36):5294-300.
    View in: PubMed
    Score: 0.003
  101. Response assessment by combined PET-CT scan versus CT scan alone using RECIST in patients with locally advanced head and neck cancer treated with chemoradiotherapy. Ann Oncol. 2010 Nov; 21(11):2278-2283.
    View in: PubMed
    Score: 0.003
  102. Management of squamous cell carcinoma of the base of tongue with chemoradiation and brachytherapy. Head Neck. 2009 Nov; 31(11):1431-8.
    View in: PubMed
    Score: 0.003
  103. Reconstruction of the through-and-through anterior mandibulectomy defect: indications and limitations of the double-skin paddle fibular free flap. Laryngoscope. 2008 Aug; 118(8):1329-34.
    View in: PubMed
    Score: 0.002
  104. Mucoepidermoid carcinoma of upper aerodigestive tract: clinicopathologic study of 78 cases with immunohistochemical analysis of Dicer expression. Virchows Arch. 2008 Jun; 452(6):629-35.
    View in: PubMed
    Score: 0.002
  105. Reconstruction of the lateral mandibulectomy defect: management based on prognosis and location and volume of soft tissue resection. Laryngoscope. 2006 Nov; 116(11):2071-80.
    View in: PubMed
    Score: 0.002
  106. Radiology quiz case 2. Parapharyngeal second branchial cleft cyst. Arch Otolaryngol Head Neck Surg. 2004 Sep; 130(9):1121, 1124-5.
    View in: PubMed
    Score: 0.002
  107. Bilateral squamous cell carcinoma of the external auditory canals. Laryngoscope. 2002 Jun; 112(6):1003-5.
    View in: PubMed
    Score: 0.002
  108. Clinical care pathway for head and neck cancer: a valuable tool for decreasing resource utilization. Arch Otolaryngol Head Neck Surg. 2002 Mar; 128(3):258-62.
    View in: PubMed
    Score: 0.002
  109. Retropharyngeal aberrant thymus. Pediatrics. 2001 Nov; 108(5):E94.
    View in: PubMed
    Score: 0.001
  110. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995 Jun 22; 64(3):196-201.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.